Kuits advises Peakdale Molecular on £12m sale of shares08 Jul 2014
Manchester commercial law firm Kuits has advised leading drug discovery firm Peakdale Molecular on the sale of £12m of its shares to a management team backed by Equistone Partners Europe Limited.
Peakdale Molecular is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and material science in the UK, across Europe and in the US.
Equistone Partners Europe Limited is an independent investment firm owned and managed by the former executives of Barclays Private Equity.
Peakdale, which operates over two sites – a headquarters in Chapel-en-le-Frith in the Peak District and a Discovery Park located in Sandwich, Kent – was founded by CEO Dr Ray Fisher in 1992 and has since grown to a £9m turnover business.
The firm was one of three acquisitions made by Equistone in forming Concept Life Sciences, an international scientific laboratory and consultancy business.
For more information about our commercial services, please contact us.